OXIS International Inc. (OXIS/OXIS.OB) Wrap Up:

Oxis International, Inc. engages in the research and development of technologies and therapeutic products in the field of oxidative stress/inflammatory reaction, diseases associated with damage from free radicals, and reactive oxygen species. The company holds the rights to four therapeutic classes of compounds in the area of oxidative stress and inflammation. It focuses on commercialization of programs, including MPO (myeloperoxidase), GPx (glutathionione peroxidase), and Superoxide Dismutase (Palosein/Orgotein), as well as a potent antioxidant, Ergothioneine, that might be sold over-the-counter as a dietary supplement. OXIS International offers approximately 70 research products, including...